[1]
2025. Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks. Canadian Oncology Today. 2, 3 (Nov. 2025), 22–28. DOI:https://doi.org/10.58931/cot.2025.2342.